• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number UNK AMPLATZER PFO OCCLUDER
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Arrhythmia (1721); Non specific EKG/ECG Changes (1817); Fatigue (1849); Obstruction/Occlusion (2422)
Event Date 10/13/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on an unknown date, an amplatzer patent foramen ovale (pfo) occluder was implanted.A few days after implant, patient presented with symptoms of weakness, palpitations, and extrasystoles.On (b)(6) 2023, a coronary angiography was performed, and a congenital malformation (left coronary origin from right coronary) was noticed with a left coronary compression from the device.On (b)(6) 2023, the device was explanted by open heart surgery.The patient was reported stable after the explant procedure.
 
Manufacturer Narrative
An event of the patient having weakness, palpitations and extrasystole symptoms was reported.Information from the field indicated that the patient had a congenital malformation with the left coronary origin from right coronary.Imaging was received from the field which was examined by abbott medical affairs.The review found that the still angiogram showed partial compression of the left coronary artery originating from the right coronary artery by the inferior edge of the right atrial disc of the amplatzer pfo device.There was blood flow through the compression site, but this could be impacted by physical activity.The compression of the artery could cause the symptoms reported.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18092055
MDR Text Key327623498
Report Number2135147-2023-04910
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER PFO OCCLUDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-